Durable clinical responses and long-term follow-up of stage III-IV non-small-cell lung cancer (NSCLC) patients treated with IDO peptide vaccine in a phase I study – a brief research report User montaukwhaler, in the non small cell lung cancer subreddit, 04 Sep 2018